JMBM served as legal counsel to Intravenous Therapy Services in the $13 million sale of the company to BioScrip Inc. The Burbank, Calif.-based home infusion pharmaceutical provider will operate under publicly held BioScrip's infusion division, but will continue to be run by its current president and CEO.